Efficacy of recombinant erythropoietin for the late treatment of anemia of prematurity in a level IV neonatal intensive care unit: a retrospective single-center cohort study.

Objective: To describe the population to which we administered recombinant erythropoietin and to determine the effectiveness of this treatment as quantified by the change in hematocrit.

Study Design: This retrospective chart review study included infants who received erythropoietin for the treatment of anemia of prematurity.

Results: There were 132 infants representing 162 unique treatment courses included in the study.